Get started
Author

Luca Marzi

Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis
2012 · Antonio Colecchia, Lucia Montrone, et al. · Gastroenterology · 553
PDF
Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods
2012 · D. Festi, R. Schiumerini, et al. · Alimentary Pharmacology & Therapeutics · 187
PDF
Liver Angiopoietin‐2 Is a Key Predictor of D e N ovo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals
2018 · Francesca Faillaci, Luca Marzi, et al. · Hepatology · 126
PDF
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
2018 · Ana Lleo, Andrea Aglitti, et al. · Digestive and Liver Disease · 65
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study
2017 · Rosina Critelli, Fabiola Milosa, et al. · Cell Death and Disease · 61
PDF
Gut Microbiota and Its Pathophysiology in Disease Paradigms
2011 · Davide Festi, Ramona Schiumerini, et al. · Digestive Diseases · 59
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
2020 · Angelo Sangiovanni, Eleonora Alimenti, et al. · Journal of Hepatology · 58
Food and Nutrition in the Pathogenesis of Liver Damage
2021 · Andrea Mega, Luca Marzi, et al. · Nutrients · 51
PDF
Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance
2019 · Francesco Paolo Russo, Alberto Zanetto, et al. · Journal of Viral Hepatitis · 38
Impact of a Multidisciplinary Team on Alcohol Recidivism and Survival After Liver Transplant for Alcoholic Disease
2018 · P. Magistri, L. Marzi, et al. · Transplantation Proceedings · 36
High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinoma
2018 · M. Persico, A. Aglitti, et al. · Alimentary Pharmacology & Therapeutics · 34
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC
2022 · Luca Marzi, Andrea Mega, et al. · Cancers · 21
PDF
Metabolic Disorders After Liver Transplantation
2020 · Stefano Gitto, Margherita Falcini, et al. · Metabolic Syndrome and Related Disorders · 19
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study
2020 · Stefano Gitto, Nicola De Maria, et al. · European Journal of Internal Medicine · 17
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis
2023 · Rodolfo Sacco, Daryl Ramai, et al. · Cancers · 16
PDF
Physical activity in liver transplant recipients: a large multicenter study
2023 · Stefano Gitto, Lucia Golfieri, et al. · Internal and Emergency Medicine · 14
PDF
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver
2024 · Luca Marzi, Andrea Mega, et al. · International Journal of Molecular Sciences · 9
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study
2022 · Stefano Gitto, Paolo Magistri, et al. · Annals of Hepatology · 9
PDF
Angiopoietin‐2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma
2019 · Paola Todesca, Luca Marzi, et al. · Hepatology · 9
New Treatment Options for MASLD Patients with Type 2 Diabetes
2026 · Andrea Mega, Chiara Turri, et al. · Life · 8
PDF
Clinical Outcomes with Long-Term Sorafenib Treatment of Patients with Hepatocellular Carcinoma: A Multicenter Real-Life Study
2018 · Rodolfo Sacco, Alessandro Granito, et al. · Future Oncology · 8
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study
2025 · Alessandro Vitale, Jung Sun Kim, et al. · Liver Cancer · 7
PDF
"Will Artificial Intelligence Unveil Hepatocellular Carcinoma?"
2021 · Luca Marzi · Biomedical Journal of Scientific & Technical Research · 7
PDF
IFN-free DAA treatment of cirrhotic HCV patients with or without history of HCC: a multicenter prospective trial in Italy
2018 · A. Sangiovanni, E. Alimenti, et al. · Journal of Hepatology · 7
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study
2025 · Edoardo G. Giannini, Andrea Pasta, et al. · Digestive and Liver Disease · 6
PDF
Works count: 70
Citation count: 1,475
H-index: 15
I10-index: 16
Year
Topic
Type